Sylvia Villeneuve1, Bruce R Reed2, Cindee M Madison2, Miranka Wirth2, Natalie L Marchant2, Stephen Kriger2, Wendy J Mack2, Nerses Sanossian2, Charles DeCarli2, Helena C Chui2, Michael W Weiner2, William J Jagust2. 1. From the Helen Wills Neuroscience Institute (S.V., C.M.M., M.W., W.J.J.), University of California Berkeley; Department of Neurology (B.R.R., C.D.), University of California Davis; Department of Old Age Psychiatry (N.L.M.), Institute of Psychiatry, King's College London, UK; Center for Imaging of Neurodegenerative Diseases (S.K., M.W.W.), University of California San Francisco; and Departments of Preventive Medicine (W.J.M.) and Neurology (N.S., H.C.C.), University of Southern California, Los Angeles. sylvia.villeneuve@berkeley.edu. 2. From the Helen Wills Neuroscience Institute (S.V., C.M.M., M.W., W.J.J.), University of California Berkeley; Department of Neurology (B.R.R., C.D.), University of California Davis; Department of Old Age Psychiatry (N.L.M.), Institute of Psychiatry, King's College London, UK; Center for Imaging of Neurodegenerative Diseases (S.K., M.W.W.), University of California San Francisco; and Departments of Preventive Medicine (W.J.M.) and Neurology (N.S., H.C.C.), University of Southern California, Los Angeles.
Abstract
OBJECTIVE: The objective of this study was to define whether vascular risk factors interact with β-amyloid (Aβ) in producing changes in brain structure that could underlie the increased risk of Alzheimer disease (AD). METHODS: Sixty-six cognitively normal and mildly impaired older individuals with a wide range of vascular risk factors were included in this study. The presence of Aβ was assessed using [(11)C]Pittsburgh compound B-PET imaging, and cortical thickness was measured using 3-tesla MRI. Vascular risk was measured with the Framingham Coronary Risk Profile Index. RESULTS: Individuals with high levels of vascular risk factors have thinner frontotemporal cortex independent of Aβ. These frontotemporal regions are also affected in individuals with Aβ deposition, but the latter show additional thinning in parietal cortices. Aβ and vascular risk were found to interact in posterior (especially in parietal) brain regions, where Aβ has its greatest effect. In this way, the negative effect of Aβ in posterior regions is increased by the presence of vascular risk. CONCLUSION: Aβ and vascular risk interact to enhance cortical thinning in posterior brain regions that are particularly vulnerable to AD. These findings give insight concerning the mechanisms whereby vascular risk increases the likelihood of developing AD and supports the therapeutic intervention of controlling vascular risk for the prevention of AD.
OBJECTIVE: The objective of this study was to define whether vascular risk factors interact with β-amyloid (Aβ) in producing changes in brain structure that could underlie the increased risk of Alzheimer disease (AD). METHODS: Sixty-six cognitively normal and mildly impaired older individuals with a wide range of vascular risk factors were included in this study. The presence of Aβ was assessed using [(11)C]Pittsburgh compound B-PET imaging, and cortical thickness was measured using 3-tesla MRI. Vascular risk was measured with the Framingham Coronary Risk Profile Index. RESULTS: Individuals with high levels of vascular risk factors have thinner frontotemporal cortex independent of Aβ. These frontotemporal regions are also affected in individuals with Aβ deposition, but the latter show additional thinning in parietal cortices. Aβ and vascular risk were found to interact in posterior (especially in parietal) brain regions, where Aβ has its greatest effect. In this way, the negative effect of Aβ in posterior regions is increased by the presence of vascular risk. CONCLUSION: Aβ and vascular risk interact to enhance cortical thinning in posterior brain regions that are particularly vulnerable to AD. These findings give insight concerning the mechanisms whereby vascular risk increases the likelihood of developing AD and supports the therapeutic intervention of controlling vascular risk for the prevention of AD.
Authors: Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg Journal: Neuroimage Date: 2010-10-28 Impact factor: 6.556
Authors: Jessica B S Langbaum; Kewei Chen; Lenore J Launer; Adam S Fleisher; Wendy Lee; Xiaofen Liu; Hillary D Protas; Stephanie A Reeder; Daniel Bandy; Meixiang Yu; Richard J Caselli; Eric M Reiman Journal: Neurobiol Aging Date: 2011-08-06 Impact factor: 4.673
Authors: Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski Journal: Lancet Neurol Date: 2010-01 Impact factor: 44.182
Authors: Eric D Vidoni; Hung-Wen Yeh; Jill K Morris; Kathy L Newell; Abdulfattah Alqahtani; Nicole C Burns; Jeffrey M Burns; Sandra A Billinger Journal: Neurodegener Dis Date: 2016-01-13 Impact factor: 2.977
Authors: Hee Jin Kim; Seongbeom Park; Hanna Cho; Young Kyoung Jang; Jin San Lee; Hyemin Jang; Yeshin Kim; Ko Woon Kim; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Michael W Weiner; William J Jagust; Gil D Rabinovici; Charles DeCarli; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo Journal: JAMA Neurol Date: 2018-08-01 Impact factor: 18.302
Authors: Jessica M Foley; David H Salat; Nikki H Stricker; Regina E McGlinchey; William P Milberg; Laura J Grande; Elizabeth C Leritz Journal: Am J Alzheimers Dis Other Demen Date: 2015-05-24 Impact factor: 2.035
Authors: Vijay K Ramanan; Scott A Przybelski; Jonathan Graff-Radford; Anna M Castillo; Val J Lowe; Michelle M Mielke; Rosebud O Roberts; Robert I Reid; David S Knopman; Clifford R Jack; Ronald C Petersen; Prashanthi Vemuri Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Jagan A Pillai; Robert S Butler; Aaron Bonner-Jackson; James B Leverenz Journal: Dement Geriatr Cogn Disord Date: 2016-09-14 Impact factor: 2.959